{"denoms":[{"counts":[{"groupId":"BG000","value":"233"},{"groupId":"BG001","value":"116"},{"groupId":"BG002","value":"349"}],"units":"Participants"}],"groups":[{"description":"Patients randomized to the rucaparib arm.","id":"BG000","title":"Rucaparib"},{"description":"Patients randomized to the chemotherapy arm.","id":"BG001","title":"Chemotherapy"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"38","upperLimit":"81","value":"58.0"},{"groupId":"BG001","lowerLimit":"38","upperLimit":"85","value":"58.5"},{"groupId":"BG002","lowerLimit":"38","upperLimit":"85","value":"58.0"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"233"},{"groupId":"BG001","value":"116"},{"groupId":"BG002","value":"349"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"219"},{"groupId":"BG001","value":"113"},{"groupId":"BG002","value":"332"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"6"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"125"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"197"}],"title":"ECOG 0"},{"measurements":[{"groupId":"BG000","value":"108"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"152"}],"title":"ECOG 1"}]}],"description":"Eastern Cooperative Oncology Group (ECOG) Performance Status Scale. ECOG 0 = Fully active, able to carry on all pre-disease performance without restriction. ECOG 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (eg, light house work or office work).","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG at Baseline","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"134"},{"groupId":"BG001","value":"68"},{"groupId":"BG002","value":"202"}],"title":"2"},{"measurements":[{"groupId":"BG000","value":"58"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"86"}],"title":"3"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"34"}],"title":"4"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"12"}],"title":"5"},{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"15"}],"title":">5"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Number of Prior Chemotherapy Regimens","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"18"}],"title":"1"},{"measurements":[{"groupId":"BG000","value":"156"},{"groupId":"BG001","value":"74"},{"groupId":"BG002","value":"230"}],"title":"2"},{"measurements":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"76"}],"title":"3"},{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"18"}],"title":"4"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}],"title":"5"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"4"}],"title":">5"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Number of Prior Platinum Regimens","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"120"},{"groupId":"BG001","value":"59"},{"groupId":"BG002","value":"179"}],"title":"Platinum resistant"},{"measurements":[{"groupId":"BG000","value":"65"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"96"}],"title":"Partially platinum-sensitive"},{"measurements":[{"groupId":"BG000","value":"48"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"74"}],"title":"Platinum sensitive"}]}],"description":"* Platinum resistant: patients who progressed ≥ 1 to \\< 6 months after the last dose of platinum-based chemotherapy;\n* Partially platinum-sensitive: patients who progressed ≥ 6 to \\< 12 months after last dose of platinum-based chemotherapy; and\n* Platinum sensitive: patients who progressed ≥ 12 months after last dose of platinum-based chemotherapy","paramType":"COUNT_OF_PARTICIPANTS","title":"Randomization Stratification: Platinum Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"181"},{"groupId":"BG001","value":"79"},{"groupId":"BG002","value":"260"}],"title":"BRCA1"},{"measurements":[{"groupId":"BG000","value":"52"},{"groupId":"BG001","value":"36"},{"groupId":"BG002","value":"88"}],"title":"BRCA2"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"Non-BRCA"}]}],"description":"* BRCA1: patients with a deleterious breast cancer susceptibility gene 1 (BRCA1) mutation in their tumor\n* BRCA2: patients with a deleterious breast cancer susceptibility gene 2 (BRCA2) mutation in their tumor\n* Non-BRCA: patients without a BRCA mutation in their tumor","paramType":"COUNT_OF_PARTICIPANTS","title":"Combined Local and Central Lab BRCA Mutation Results","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"198"},{"groupId":"BG001","value":"95"},{"groupId":"BG002","value":"293"}],"title":"Germline"},{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"54"}],"title":"Somatic"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"}],"title":"Not Available"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Mutation Type","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"23"}]}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Patients with a BRCA Reversion Mutation","unitOfMeasure":"Participants"}]}